is digital currency taxable Knowledge graph

Shanghai heavy releaseOn December 10th, the Great Hall of the People in Beijing met with the heads of major international economic organizations who came to China to attend the "1+10" Dialogue, expressing full confidence in achieving this year's economic growth target and continuing to play the role of the biggest engine of world economic growth.Listed companies can achieve extensive growth through mergers and acquisitions, and mergers and acquisitions have a positive effect on the overall share price of A-share listed companies as bidders. With the continuous increase of China's M&A support policies since 2024, the A-share market is expected to usher in a big era of M&A. The last merger and reorganization was so hot in 2014. Is this also a sign that the market will go bullish in the future?

Specifically, it includes the following points: 1. Landing a number of representative M&A cases in key industries; 2. Sort out the list of main enterprises in the listed chain of key industries; 3. Promote the transformation and upgrading of traditional industries; 4. Sort out the list of potential key M&A target enterprises; 5, the establishment of 10 billion yuan biomedical industry M&A fund; 6. Accelerate the merger of securities companies; 7. Explore innovative pilot projects for domestic technology-based enterprises to participate in M&A loans; 8. Improve M&A service efficiency and regulatory inclusiveness.A-shares: the latest tone of the top management, foreign capital continues to increase! Can we have a big repair on Wednesday?The latest high-level tuning

Analysis of exchange rate trendThe General Office of the Shanghai Municipal People's Government issued the Action Plan for Shanghai to Support the Merger and Reorganization of Listed Companies (2025-2027). Among them, it is proposed to strive to land a number of representative M&A cases in key industries by 2027, and cultivate about 10 internationally competitive listed companies in key industries such as integrated circuits, biomedicine and new materials, forming a scale of M&A transactions of 300 billion yuan and activating total assets of over 2 trillion yuan.